Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine. [artículo]
Por: Barrio, Francisco | Boutriau, Dominique | Cabanillas, Lucia | Caubet, Magalie | Centeno, Fernando | De Torres, Maria Jose | Espín, José | Esporrin, Carlos | García-Sicilia, José | Merino, José Manuel | Mesaros, Narcisa | Miller, Jacqueline M | Moreno-Pérez, David | Moro, Manuel | Muro, Marta | Navarro, Maria-Luisa | Omeñaca, Félix | Ruiz-Contreras, Jesús | Ruiz Contreras, Jesús [Pediatría]
.
Colaborador(es): Servicio de Pediatría-Neonatología.
Editor: The Pediatric infectious disease journal, 2012; 2012Descripción: 31(10):1074-7.Recursos en línea: Solicitar documento Resumen: BACKGROUND: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been reported to induce different MenC antibody responses depending on the priming vaccines, with a possible impact on long-term protection. Here, the five-year persistence of immune responses induced by a booster dose of Hib-MenC-TT was evaluated in toddlers primed with either Hib-MenC-TT or MenC-TT.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC981 (Navegar estantería) | Disponible |
Formato Vancouver:
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F et al. Five-year antibody persistence and safety following a booster dose of combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Tejedor JC, Merino JM, Moro M, Navarro ML, Espín J, Omeñaca F, García-Sicilia
J, Moreno-Pérez D, Ruiz-Contreras J, Centeno F, Barrio F, Cabanillas L, Muro M,
Esporrin C, De Torres MJ, Caubet M, Boutriau D, Miller JM, Mesaros N. Five-year
antibody persistence and safety following a booster dose of combined Haemophilus
influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate
vaccine. Pediatr Infect Dis J. 2012 Oct;31(10):1074-7.
Contiene 19 referencias
BACKGROUND: Booster vaccination with the combined Haemophilus influenza type b-Neisseria meningitides serogroup C-tetanus toxoid vaccine (Hib-MenC-TT) has been reported to induce different MenC antibody responses depending on the priming vaccines, with a possible impact on long-term protection. Here, the five-year persistence of immune responses induced by a booster dose of Hib-MenC-TT was evaluated in toddlers primed with either Hib-MenC-TT or MenC-TT.
No hay comentarios para este ejemplar.